Physician profile
Todd V Bierman
NPI 1285054031
$8,458.39
in general payments reported to CMS, 2019-2025
8 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.34 · 2022: $6,260 · 2023: $611 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,080 · Food and Beverage: $1,018 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,080.24 |
| Food and Beverage | $1,018.17 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,782.98 | 2022-2023 | Da Vinci Surgical System |
| Davol INC. | $1,412.22 | 2021-2025 | Phasix Mesh |
| Phathom Pharmaceuticals, INC. | $99.18 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $86.96 | 2021-2022 | |
| Ethicon US, LLC | $23.64 | 2021 | |
| Stryker Corporation | $22.61 | 2025 | Molli |
| Urgo Medical North America, LLC | $15.53 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Inari Medical, INC. | $15.27 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Bierman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.